Ketoconazole Cream 2% Recalled Due to Manufacturing Temperature Abuse
McKesson Medical-Surgical is recalling Ketoconazole Cream 2% (60-gram tubes) distributed nationwide due to cGMP deviations involving temperature abuse during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard—manufacturing temperature control deviations—is a manufacturing compliance issue rather than a direct safety threat.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Ketoconazole Cream 2% (NDC 0168-0099-60) in 60-gram tubes, manufactured by Nycomed Inc. The product was distributed nationwide throughout the USA.
The recall was initiated due to cGMP deviations involving temperature abuse during the manufacturing process.
Specific lot numbers cannot be identified by individual customers. McKesson Medical-Surgical included distribution dates and shipping information in recall notification letters to customers. Healthcare providers and patients with this product should contact their McKesson supplier for instructions regarding quarantine, return, and replacement.
The recalled product
- Product
- KETOCONAZOLE (KETOCONAZOLE)
- Brand
- KETOCONAZOLE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Topical Antifungal
- Hazard
- temperature-abuse
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 0301680099156
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27